Glycomics Market Size, Share & Trends Analysis Report 2023: Enzymes, Kits, Reagents, Instruments, Drug Discovery & Development, Diagnostics – Global Market to Reach $4.92 Billion by 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Glycomics Market Size, Share & Trends Analysis Report By Product (Enzymes, Kits, Reagents, Instruments), By Application (Drug Discovery & Development, Diagnostics), By End Use, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.

The global glycomics market size is expected to reach USD 4.92 billion by 2030 and is estimated to register a CAGR of 14.6% during 2023-2030

Growing research and development in the glycomics space, owing to its crucial role in various biological processes, is projected to drive the global market. Moreover, the increasing demand for personalized medicine has further supported industry growth as glycomics plays a significant role in developing glycan-based diagnostic solutions.

Recently glycomics have shown promise in identifying disease-specific glycan biomarkers for early detection and diagnosis of various health conditions. The potential for glycan biomarkers has attracted interest from the healthcare and diagnostics industries. For instance, in November 2021 GlycoPath Inc. launched its glycan imaging kit for glycoproteomic analysis of clinical and research samples. The newly launched kit is applicable for tissue imaging to biofluid profiling and is easily adaptable with many kinds of platforms.

Technological advancements have also contributed to the high demand for glycomics instruments. Procedures such as protein characterizations are evolving into advanced technologies such as Mass Spectrometry (MS), High-Performance Liquid Chromatography (HPLC), and Capillary Electrophoresis (CE) in chemical and biochemical research. These advanced techniques provide rapid and precise results. Glycomics technologies currently available are standardized and streamlined.

Furthermore, the increase in the number of research institutes that support glycan-based research is a major factor anticipated to fuel market growth in the near future. The National Center for Biomedical Glycomics (NCBG) focuses on the dissemination & development of technologies and tools for analytical genomics.

The organization’s analytical, technical R&D program involves the development of glycan tools, glycoconjugate, and informatics. In addition, the National Cancer Institute consists of the Alliance of Glycobiologists for Cancer Research, which aims at studying the structure as well as functions of glycans for cancer study.

Glycomics Market Report Highlights

• Enzymes segment dominated the industry in 2022 with a revenue share of 29.2% and is attributed to the wide application of enzymes in glycan-based studies, diagnostics, and drug discovery
• Drug discovery and development is the largest application of the market, whereas the diagnostics segment is expected to witness the fastest growth owing to the growing interest of industry players in developing glycan-based diagnostics
• In the end-use segment, the academic & research institutes segment dominated the market with a revenue share of 38.2%. The higher revenue growth is attributed to the extensive adoption of glycan structure data analysis by research centers and the increasing preference for glycomics for training & educational purposes
• North America region dominated the global market in 2022 with a revenue share of 39.1%. The high growth of the region is governed by factors such as the presence of a large number of research institutes and supportive government legislation.

Competitive Landscape

• Thermo Fisher Scientific, Inc
• Merck KGaA
• Agilent Technologies Inc.
• Bruker
• New England Biolabs
• Shimadzu Corporation
• Waters Corporation
• Takara Bio Inc
• Asparia Glycomics
• RayBiotech Life, Inc.

Key Attributes:

Report Attribute	Details
No. of Pages	180
Forecast Period	2022 – 2030
Estimated Market Value (USD) in 2022	$1.65 Billion
Forecasted Market Value (USD) by 2030	$4.92 Billion
Compound Annual Growth Rate	14.6%
Regions Covered	Global

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

2.1. Market Snapshot

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/Ancillary Market Outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.1.1. Increasing focus on glycomics and proteomics research

3.2.1.2. Rising R & D investments by pharmaceutical and biotechnology companies

3.2.1.3. Technological advancements

3.2.1.4. Increasing focus on developing alternative to animal testing

3.2.2. Market Restraint Analysis

3.2.2.1. High cost of glycomics instruments

3.2.2.2. Stringent government policies and regulations

3.3. Industry Analysis Tools

3.3.1. Porter’s Five Forces Analysis

3.3.2. PESTEL Analysis

3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

4.1. Glycomics Market: Product Movement Analysis

4.2. Enzymes

4.2.1. Enzymes Market, 2018 – 2030 (USD Million)

4.2.2. Glycosidases

4.2.3. Glycosyltransferases

4.2.4. Neuraminidases

4.2.5. Sialyltransferases

4.3. Kits

4.3.1. Kits Market, 2018 – 2030 (USD Million)

4.3.2. Glycan labeling kits

4.3.3. Glycan purification kits

4.3.4. Glycan release kits

4.4. Reagents

4.4.1. Reagents Market, 2018 – 2030 (USD Million)

4.4.2. Glycoproteins

4.4.3. Monosaccharides

4.4.4. Oligosaccharides

4.5. Instruments

4.5.1. Instruments Market, 2018 – 2030 (USD Million)

4.5.2. Mass spectrometers

4.5.3. HPLC

4.5.4. MALDI-TOF

4.5.5. Array systems

Chapter 5. Application Business Analysis

5.1. Glycomics Market: Application Movement Analysis

5.2. Drug Discovery & Development

5.2.1. Drug Discovery & Development Market, 2018 – 2030 (USD Million)

5.3. Diagnostics

Chapter 6. End Use Business Analysis

6.1. Glycomics Market: End Use Movement Analysis

6.2. Pharmaceutical & Biotechnology Companies

6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 – 2030 (USD Million)

6.3. Academic & Research Institutes

6.4. Biopharmaceutical Companies

6.5. CROs

Chapter 7. Regional Business Analysis

7.1. Glycomics Market Share By Region, 2022 & 2030

For more information about this report visit https://www.researchandmarkets.com/r/z8kknl

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900